Global Neuraminidase Inhibitor Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neuraminidase Inhibitor Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neuraminidase Inhibitor by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neuraminidase Inhibitor by Country/Region, 2017, 2022 & 2028

2.2 Neuraminidase Inhibitor Segment by Type

2.2.1 Zanamivir

2.2.2 Oseltamivir

2.2.3 Peramivir

2.2.4 Laninamivir

2.3 Neuraminidase Inhibitor Sales by Type

2.3.1 Global Neuraminidase Inhibitor Sales Market Share by Type (2017-2022)

2.3.2 Global Neuraminidase Inhibitor Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neuraminidase Inhibitor Sale Price by Type (2017-2022)

2.4 Neuraminidase Inhibitor Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Drug Stores

2.4.3 Retail Stores

2.4.4 Others

2.5 Neuraminidase Inhibitor Sales by Application

2.5.1 Global Neuraminidase Inhibitor Sale Market Share by Application (2017-2022)

2.5.2 Global Neuraminidase Inhibitor Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neuraminidase Inhibitor Sale Price by Application (2017-2022)

3 Global Neuraminidase Inhibitor by Company

3.1 Global Neuraminidase Inhibitor Breakdown Data by Company

3.1.1 Global Neuraminidase Inhibitor Annual Sales by Company (2020-2022)

3.1.2 Global Neuraminidase Inhibitor Sales Market Share by Company (2020-2022)

3.2 Global Neuraminidase Inhibitor Annual Revenue by Company (2020-2022)

3.2.1 Global Neuraminidase Inhibitor Revenue by Company (2020-2022)

3.2.2 Global Neuraminidase Inhibitor Revenue Market Share by Company (2020-2022)

3.3 Global Neuraminidase Inhibitor Sale Price by Company

3.4 Key Manufacturers Neuraminidase Inhibitor Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neuraminidase Inhibitor Product Location Distribution

3.4.2 Players Neuraminidase Inhibitor Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neuraminidase Inhibitor by Geographic Region

4.1 World Historic Neuraminidase Inhibitor Market Size by Geographic Region (2017-2022)

4.1.1 Global Neuraminidase Inhibitor Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neuraminidase Inhibitor Annual Revenue by Geographic Region

4.2 World Historic Neuraminidase Inhibitor Market Size by Country/Region (2017-2022)

4.2.1 Global Neuraminidase Inhibitor Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neuraminidase Inhibitor Annual Revenue by Country/Region

4.3 Americas Neuraminidase Inhibitor Sales Growth

4.4 APAC Neuraminidase Inhibitor Sales Growth

4.5 Europe Neuraminidase Inhibitor Sales Growth

4.6 Middle East & Africa Neuraminidase Inhibitor Sales Growth

5 Americas

5.1 Americas Neuraminidase Inhibitor Sales by Country

5.1.1 Americas Neuraminidase Inhibitor Sales by Country (2017-2022)

5.1.2 Americas Neuraminidase Inhibitor Revenue by Country (2017-2022)

5.2 Americas Neuraminidase Inhibitor Sales by Type

5.3 Americas Neuraminidase Inhibitor Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neuraminidase Inhibitor Sales by Region

6.1.1 APAC Neuraminidase Inhibitor Sales by Region (2017-2022)

6.1.2 APAC Neuraminidase Inhibitor Revenue by Region (2017-2022)

6.2 APAC Neuraminidase Inhibitor Sales by Type

6.3 APAC Neuraminidase Inhibitor Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neuraminidase Inhibitor by Country

7.1.1 Europe Neuraminidase Inhibitor Sales by Country (2017-2022)

7.1.2 Europe Neuraminidase Inhibitor Revenue by Country (2017-2022)

7.2 Europe Neuraminidase Inhibitor Sales by Type

7.3 Europe Neuraminidase Inhibitor Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neuraminidase Inhibitor by Country

8.1.1 Middle East & Africa Neuraminidase Inhibitor Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neuraminidase Inhibitor Revenue by Country (2017-2022)

8.2 Middle East & Africa Neuraminidase Inhibitor Sales by Type

8.3 Middle East & Africa Neuraminidase Inhibitor Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neuraminidase Inhibitor

10.3 Manufacturing Process Analysis of Neuraminidase Inhibitor

10.4 Industry Chain Structure of Neuraminidase Inhibitor

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neuraminidase Inhibitor Distributors

11.3 Neuraminidase Inhibitor Customer

12 World Forecast Review for Neuraminidase Inhibitor by Geographic Region

12.1 Global Neuraminidase Inhibitor Market Size Forecast by Region

12.1.1 Global Neuraminidase Inhibitor Forecast by Region (2023-2028)

12.1.2 Global Neuraminidase Inhibitor Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neuraminidase Inhibitor Forecast by Type

12.7 Global Neuraminidase Inhibitor Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline

13.1.1 GlaxoSmithKline Company Information

13.1.2 GlaxoSmithKline Neuraminidase Inhibitor Product Offered

13.1.3 GlaxoSmithKline Neuraminidase Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Main Business Overview

13.1.5 GlaxoSmithKline Latest Developments

13.2 Gilead Sciences

13.2.1 Gilead Sciences Company Information

13.2.2 Gilead Sciences Neuraminidase Inhibitor Product Offered

13.2.3 Gilead Sciences Neuraminidase Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Gilead Sciences Main Business Overview

13.2.5 Gilead Sciences Latest Developments

13.3 F. Hoffman-La Roche

13.3.1 F. Hoffman-La Roche Company Information

13.3.2 F. Hoffman-La Roche Neuraminidase Inhibitor Product Offered

13.3.3 F. Hoffman-La Roche Neuraminidase Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 F. Hoffman-La Roche Main Business Overview

13.3.5 F. Hoffman-La Roche Latest Developments

13.4 BioCryst

13.4.1 BioCryst Company Information

13.4.2 BioCryst Neuraminidase Inhibitor Product Offered

13.4.3 BioCryst Neuraminidase Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 BioCryst Main Business Overview

13.4.5 BioCryst Latest Developments

13.5 Daiichi Sankyo

13.5.1 Daiichi Sankyo Company Information

13.5.2 Daiichi Sankyo Neuraminidase Inhibitor Product Offered

13.5.3 Daiichi Sankyo Neuraminidase Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Daiichi Sankyo Main Business Overview

13.5.5 Daiichi Sankyo Latest Developments

14 Research Findings and Conclusion

Table 1. Neuraminidase Inhibitor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neuraminidase Inhibitor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Zanamivir

Table 4. Major Players of Oseltamivir

Table 5. Major Players of Peramivir

Table 6. Major Players of Laninamivir

Table 7. Global Neuraminidase Inhibitor Sales by Type (2017-2022) & (K Units)

Table 8. Global Neuraminidase Inhibitor Sales Market Share by Type (2017-2022)

Table 9. Global Neuraminidase Inhibitor Revenue by Type (2017-2022) & ($ million)

Table 10. Global Neuraminidase Inhibitor Revenue Market Share by Type (2017-2022)

Table 11. Global Neuraminidase Inhibitor Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Neuraminidase Inhibitor Sales by Application (2017-2022) & (K Units)

Table 13. Global Neuraminidase Inhibitor Sales Market Share by Application (2017-2022)

Table 14. Global Neuraminidase Inhibitor Revenue by Application (2017-2022)

Table 15. Global Neuraminidase Inhibitor Revenue Market Share by Application (2017-2022)

Table 16. Global Neuraminidase Inhibitor Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Neuraminidase Inhibitor Sales by Company (2020-2022) & (K Units)

Table 18. Global Neuraminidase Inhibitor Sales Market Share by Company (2020-2022)

Table 19. Global Neuraminidase Inhibitor Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Neuraminidase Inhibitor Revenue Market Share by Company (2020-2022)

Table 21. Global Neuraminidase Inhibitor Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Neuraminidase Inhibitor Producing Area Distribution and Sales Area

Table 23. Players Neuraminidase Inhibitor Products Offered

Table 24. Neuraminidase Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Neuraminidase Inhibitor Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Neuraminidase Inhibitor Sales Market Share Geographic Region (2017-2022)

Table 29. Global Neuraminidase Inhibitor Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Neuraminidase Inhibitor Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Neuraminidase Inhibitor Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Neuraminidase Inhibitor Sales Market Share by Country/Region (2017-2022)

Table 33. Global Neuraminidase Inhibitor Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Neuraminidase Inhibitor Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Neuraminidase Inhibitor Sales by Country (2017-2022) & (K Units)

Table 36. Americas Neuraminidase Inhibitor Sales Market Share by Country (2017-2022)

Table 37. Americas Neuraminidase Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Neuraminidase Inhibitor Revenue Market Share by Country (2017-2022)

Table 39. Americas Neuraminidase Inhibitor Sales by Type (2017-2022) & (K Units)

Table 40. Americas Neuraminidase Inhibitor Sales Market Share by Type (2017-2022)

Table 41. Americas Neuraminidase Inhibitor Sales by Application (2017-2022) & (K Units)

Table 42. Americas Neuraminidase Inhibitor Sales Market Share by Application (2017-2022)

Table 43. APAC Neuraminidase Inhibitor Sales by Region (2017-2022) & (K Units)

Table 44. APAC Neuraminidase Inhibitor Sales Market Share by Region (2017-2022)

Table 45. APAC Neuraminidase Inhibitor Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Neuraminidase Inhibitor Revenue Market Share by Region (2017-2022)

Table 47. APAC Neuraminidase Inhibitor Sales by Type (2017-2022) & (K Units)

Table 48. APAC Neuraminidase Inhibitor Sales Market Share by Type (2017-2022)

Table 49. APAC Neuraminidase Inhibitor Sales by Application (2017-2022) & (K Units)

Table 50. APAC Neuraminidase Inhibitor Sales Market Share by Application (2017-2022)

Table 51. Europe Neuraminidase Inhibitor Sales by Country (2017-2022) & (K Units)

Table 52. Europe Neuraminidase Inhibitor Sales Market Share by Country (2017-2022)

Table 53. Europe Neuraminidase Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Neuraminidase Inhibitor Revenue Market Share by Country (2017-2022)

Table 55. Europe Neuraminidase Inhibitor Sales by Type (2017-2022) & (K Units)

Table 56. Europe Neuraminidase Inhibitor Sales Market Share by Type (2017-2022)

Table 57. Europe Neuraminidase Inhibitor Sales by Application (2017-2022) & (K Units)

Table 58. Europe Neuraminidase Inhibitor Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Neuraminidase Inhibitor Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Neuraminidase Inhibitor Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Neuraminidase Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Neuraminidase Inhibitor Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Neuraminidase Inhibitor Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Neuraminidase Inhibitor Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Neuraminidase Inhibitor Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Neuraminidase Inhibitor Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Neuraminidase Inhibitor

Table 68. Key Market Challenges & Risks of Neuraminidase Inhibitor

Table 69. Key Industry Trends of Neuraminidase Inhibitor

Table 70. Neuraminidase Inhibitor Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Neuraminidase Inhibitor Distributors List

Table 73. Neuraminidase Inhibitor Customer List

Table 74. Global Neuraminidase Inhibitor Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Neuraminidase Inhibitor Sales Market Forecast by Region

Table 76. Global Neuraminidase Inhibitor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Neuraminidase Inhibitor Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Neuraminidase Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Neuraminidase Inhibitor Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Neuraminidase Inhibitor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Neuraminidase Inhibitor Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Neuraminidase Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Neuraminidase Inhibitor Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Neuraminidase Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Neuraminidase Inhibitor Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Neuraminidase Inhibitor Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Neuraminidase Inhibitor Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Neuraminidase Inhibitor Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Neuraminidase Inhibitor Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Neuraminidase Inhibitor Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Application (2023-2028)

Table 94. GlaxoSmithKline Basic Information, Neuraminidase Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 95. GlaxoSmithKline Neuraminidase Inhibitor Product Offered

Table 96. GlaxoSmithKline Neuraminidase Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. GlaxoSmithKline Main Business

Table 98. GlaxoSmithKline Latest Developments

Table 99. Gilead Sciences Basic Information, Neuraminidase Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 100. Gilead Sciences Neuraminidase Inhibitor Product Offered

Table 101. Gilead Sciences Neuraminidase Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Gilead Sciences Main Business

Table 103. Gilead Sciences Latest Developments

Table 104. F. Hoffman-La Roche Basic Information, Neuraminidase Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 105. F. Hoffman-La Roche Neuraminidase Inhibitor Product Offered

Table 106. F. Hoffman-La Roche Neuraminidase Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. F. Hoffman-La Roche Main Business

Table 108. F. Hoffman-La Roche Latest Developments

Table 109. BioCryst Basic Information, Neuraminidase Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 110. BioCryst Neuraminidase Inhibitor Product Offered

Table 111. BioCryst Neuraminidase Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. BioCryst Main Business

Table 113. BioCryst Latest Developments

Table 114. Daiichi Sankyo Basic Information, Neuraminidase Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 115. Daiichi Sankyo Neuraminidase Inhibitor Product Offered

Table 116. Daiichi Sankyo Neuraminidase Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Daiichi Sankyo Main Business

Table 118. Daiichi Sankyo Latest Developments

List of Figures

Figure 1. Picture of Neuraminidase Inhibitor

Figure 2. Neuraminidase Inhibitor Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neuraminidase Inhibitor Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Neuraminidase Inhibitor Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neuraminidase Inhibitor Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Zanamivir

Figure 10. Product Picture of Oseltamivir

Figure 11. Product Picture of Peramivir

Figure 12. Product Picture of Laninamivir

Figure 13. Global Neuraminidase Inhibitor Sales Market Share by Type in 2021

Figure 14. Global Neuraminidase Inhibitor Revenue Market Share by Type (2017-2022)

Figure 15. Neuraminidase Inhibitor Consumed in Hospital Pharmacies

Figure 16. Global Neuraminidase Inhibitor Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 17. Neuraminidase Inhibitor Consumed in Drug Stores

Figure 18. Global Neuraminidase Inhibitor Market: Drug Stores (2017-2022) & (K Units)

Figure 19. Neuraminidase Inhibitor Consumed in Retail Stores

Figure 20. Global Neuraminidase Inhibitor Market: Retail Stores (2017-2022) & (K Units)

Figure 21. Neuraminidase Inhibitor Consumed in Others

Figure 22. Global Neuraminidase Inhibitor Market: Others (2017-2022) & (K Units)

Figure 23. Global Neuraminidase Inhibitor Sales Market Share by Application (2017-2022)

Figure 24. Global Neuraminidase Inhibitor Revenue Market Share by Application in 2021

Figure 25. Neuraminidase Inhibitor Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Neuraminidase Inhibitor Revenue Market Share by Company in 2021

Figure 27. Global Neuraminidase Inhibitor Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Neuraminidase Inhibitor Revenue Market Share by Geographic Region in 2021

Figure 29. Global Neuraminidase Inhibitor Sales Market Share by Region (2017-2022)

Figure 30. Global Neuraminidase Inhibitor Revenue Market Share by Country/Region in 2021

Figure 31. Americas Neuraminidase Inhibitor Sales 2017-2022 (K Units)

Figure 32. Americas Neuraminidase Inhibitor Revenue 2017-2022 ($ Millions)

Figure 33. APAC Neuraminidase Inhibitor Sales 2017-2022 (K Units)

Figure 34. APAC Neuraminidase Inhibitor Revenue 2017-2022 ($ Millions)

Figure 35. Europe Neuraminidase Inhibitor Sales 2017-2022 (K Units)

Figure 36. Europe Neuraminidase Inhibitor Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Neuraminidase Inhibitor Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Neuraminidase Inhibitor Revenue 2017-2022 ($ Millions)

Figure 39. Americas Neuraminidase Inhibitor Sales Market Share by Country in 2021

Figure 40. Americas Neuraminidase Inhibitor Revenue Market Share by Country in 2021

Figure 41. United States Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Neuraminidase Inhibitor Sales Market Share by Region in 2021

Figure 46. APAC Neuraminidase Inhibitor Revenue Market Share by Regions in 2021

Figure 47. China Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Neuraminidase Inhibitor Sales Market Share by Country in 2021

Figure 54. Europe Neuraminidase Inhibitor Revenue Market Share by Country in 2021

Figure 55. Germany Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Neuraminidase Inhibitor Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Neuraminidase Inhibitor Revenue Market Share by Country in 2021

Figure 62. Egypt Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Neuraminidase Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Neuraminidase Inhibitor in 2021

Figure 68. Manufacturing Process Analysis of Neuraminidase Inhibitor

Figure 69. Industry Chain Structure of Neuraminidase Inhibitor

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles